OrthoPediatrics Corp earnings releases KIDS

OrthoPediatrics Corp last reported quarterly results on Oct 27, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $72.7 million (+18.6% year over year) and diluted EPS of -$0.25. It usually reports 12–35 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–35 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 27, 2026
27 days after quarter end
Q3 FY2026
ended Sep 30, 2026
73
+18.6%
-6
+49.6%
-0.25
+50.0%
Aug 4, 2026
35 days after quarter end
Q2 FY2026
ended Jun 30, 2026
71
+15.4%
-7
-0.7%
-0.30
+0.0%
Apr 30, 2026
30 days after quarter end
Q1 FY2026
ended Mar 31, 2026
59
+13.3%
-11
-0.3%
-0.45
+2.2%
Jan 12, 2026
12 days after quarter end
Q4 FY2025
ended Dec 31, 2025
62
+17.0%
-10
+37.1%
-0.43
+38.2%
Oct 9, 2025
9 days after quarter end
Q3 FY2025
ended Sep 30, 2025
61
+12.2%
-12
-48.7%
-0.50
-47.1%
Aug 5, 2025
36 days after quarter end
Q2 FY2025
ended Jun 30, 2025
61
+15.7%
-7
-18.0%
-0.30
-15.4%
May 7, 2025
37 days after quarter end
Q1 FY2025
ended Mar 31, 2025
52
+17.3%
-11
-36.6%
-0.46
-35.3%
Jan 13, 2025
13 days after quarter end
Q4 FY2024
ended Dec 31, 2024
53
+40.0%
-16
-140.2%
-0.69
-135.9%

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
KIDS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Warsaw, IN
SEC filer status
Accelerated filer
SEC CIK
1425450

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.